Comparison

Adalimumab

Item no. DCC-A001-25mg
Manufacturer DCChemicals
CASRN 331731-18-1
Amount 25 mg
Quantity options 100 mg 10 mg 25 mg
Category
Type Chemicals
Specific against other
Purity 0,98
Smiles S(C1C([H])=C([H])C(=C([H])C=1[H])OC(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)(N([H])C1=C([H])C([H])=C([H])C([H])=C1C(N([H])C([H])([H])C(=O)O[H])=O)(=O)=O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias 331731-18-1
Similar products 331731-18-1
Available
Manufacturer - Applications
Adalimumab (anti-TNF-alpha) is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha.
Manufacturer - Category
Therapeutic Antibodies
Molecular Weight
434.463g/mol

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close